Medifast (MED) Net Cash Flow (2010 - 2026)

Medifast (MED) has 17 years of Net Cash Flow data on file, last reported at -$17.8 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow fell 2352.72% year-over-year to -$17.8 million; the trailing twelve-month figure through Mar 2026 stood at -$20.2 million (down 248.98% YoY), and the FY2025 full-year result was -$1.6 million, up 54.23% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$17.8 million, down from -$10.2 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $36.0 million in Q1 2023 and bottomed at -$57.1 million in Q2 2022.
• The 5-year median for Net Cash Flow is $3.0 million (2024), against an average of -$1.9 million.
• The widest annual swing landed in 2023, when Net Cash Flow jumped 161.41%; it then plunged 2352.72% in 2026.
• A 5-year view of Net Cash Flow shows it stood at $18.3 million in 2022, then slumped by 198.75% to -$18.1 million in 2023, then plunged by 34.59% to -$24.4 million in 2024, then jumped by 58.05% to -$10.2 million in 2025, then slumped by 73.79% to -$17.8 million in 2026.
• The last three Net Cash Flow figures came in at -$17.8 million (Q1 2026), -$10.2 million (Q4 2025), and -$2.2 million (Q3 2025), per Business Quant data.

Peer Comparison